Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

Delayed Quote. Delayed  - 09/30 05:31:47 pm
76.4 CHF   -1.10%
07:16a NOVARTIS : late-breaking data show Cosentyx delivers high and long-l..
09/30 GlaxoSmithKline to pay $20 million to settle U.S. foreign bribery..
09/30 GSK names new head of Consumer Healthcare division
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on NOVARTIS AG
08/31 NOVARTIS : AirFluSal® Forspiro® showed superiority at 12 months over Seretide® D..
08/30 AMGEN : Novartis wins US OK for biosimilar version of Amgen's Enbrel
08/30DJFDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30DJNOVARTIS : FDA Approves Novartis's Biosimilar to Amgen's Enbrel
08/30 NOVARTIS : FDA approves Sandoz Erelzi(TM) to treat multiple inflammatory disease..
08/30 CONTRACT AWARD - J-- GOVERNMWNT OWNE : Pmi constellation: 9/1/16-8/31/17
08/30 NOVARTIS : $12,482 Federal Contract Awarded to Alcon Laboratories
08/30 NOVARTIS AG (ADR) (NYSE : NVS) Says A Picture Is Worth A Thousand Words
08/29 GLAXOSMITHKLINE : Ahmed - GSK Has Full Confidence in the Nigerian Economy
08/29 AHMED : GSK Has Full Confidence in the Nigerian Economy
08/29 NOVARTIS : convenes experts to discuss new technologies in healthcare at Interna..
08/27 Stada shareholder AOC pushes through board reshuffle
08/27 LEPLEY REELS IN TOP HONOURS FOR NOVA : Tony Burman catches up with the angling a..
08/26 NOVARTIS AG (NYSE : NVS) Announces Positive Phase III Results For MS Drug
08/26 NOVARTIS : Alcon Research Assigned Patent
08/25 NOVARTIS' : phase III MS study successfully meets endpoints
08/25 NOVARTIS : announces positive phase III results showing efficacy of BAF312 in pa..
08/24 NOVARTIS AG (NYSE : NVS) Licenses LGT209 To Cyon Therapeutics, Inc., Teams Up Wi..
08/24 NOVARTIS : Today's Cartoon (August 24 2016)
08/23 NOVARTIS : Kenya Red Cross Society and Novartis Join Forces
08/22DJEli Lilly, AstraZeneca Progress With Alzheimer's Drug
08/19 NOVARTIS : Alcon Research Assigned Patent
08/18 NOVARTIS : New drugs hope to fight neglected tropical diseases
08/18 JACOBS ENGINEERING : Awarded Contract for Novartis Biotechnology Center Expansio..
08/18 NOVARTIS : Patent Issued for Combination Therapy (USPTO 9408847)
08/18 NOVARTIS : NICE says Novartis' and Janssen's cancer drugs are not cost effective
08/17 NOVARTIS : Turkey's investigation into drugmaker Novartis 'ongoing' - official
08/17 CSL : Full Year Result 2016CSL Delivers Another Strong Performance
08/15DJStada Arzneimittel Braced for Investor Battle
08/15 NOVARTIS : Six leading scientists to receive prestigious Novartis Prizes for Imm..
08/15 NOVARTIS : Six leading scientists to receive prestigious Novartis Prizes for Imm..
08/13 NOVARTIS : Korea executives charged for bribing doctors
08/13 NOVARTIS : Korea executives charged with bribing doctors
08/13 DALTON STARS AT SALTFLEETBY AS RIVAL : Tony Burman catches up with the angling a..
08/12 JACOBS ENGINEERING : Awarded Contract for Novartis Biotechnology Center Expansio..
08/12 NOVARTIS : Korea mired in `rebate' scandal
08/12 NOVARTIS : faces potential South Korea sales ban
08/11 NOVARTIS : execs in Korea are indicted for bribing doctors
08/11 NOVARTIS : Patent Issued for Two Dimensional Forward Scanning Probe (USPTO 94025..
08/11 XENCOR : Reports Second Quarter 2016 Financial Results
08/11 NOVARTIS : "New Use" in Patent Application Approval Process (USPTO 20160213646)
08/11 NOVARTIS : execs in Korea are indicted for bribing doctors
08/11 NOVARTIS : execs indicted in bribery scandalthis time in Korea
08/11 NOVARTIS : CDK4/6 inhibitor LEE011 ribociclib receives FDA Breakthrough Therapy ..
08/11 NOVARTIS : University of York -New drugs hope to fight neglected tropical diseas..
08/10 NOVARTIS : Alcon LenSx Assigned Patent
08/06 NOVARTIS : asthma pill shows promise in small trial
08/05DJAbbVie Sues Amgen Over Humira
08/05 AstraZeneca hits 2014 Pfizer bid price, helped by Bristol's woes
08/04 NOVARTIS : BioLabs San Diego Launches Southern California Operations With Biocom..
08/04 NOVARTIS : Guidepost Solutions Appoints Sokolow Former Novartis Services General..
08/04 NOVARTIS : Patent Issued for Pharmaceutical Composition (USPTO 9399021)
08/04 NOVARTIS : NICE recommends secukinumab for people with ankylosing spondylitis
08/04 Teva Pharm eyes more acquisitions after buying Allergan's generics business
08/04 NOVARTIS : Verona's laura waitts to marry michael pollock
08/03 NOVARTIS : Alcon achieves US approval for CyPass Micro-Stent, a micro invasive s..
08/03 NOVARTIS : CDK4/6 inhibitor LEE011 (ribociclib) receives FDA Breakthrough Therap..
08/02 NOVARTIS : Alcon achieves US approval for CyPass® Micro-Stent, a micro invasive ..
08/01 GSK and Google parent forge 540 million pound bioelectronic medicines firm
08/01DJGlaxo, Alphabet Plan $700 Million Bioelectric Treatment Venture
07/29 NOVARTIS INDIA : Q1 NET PROFIT AT Rs19 CRORE
07/28 NOVARTIS : "2-Carboxamide Cycloamino Urea Derivatives in Combination with HSP90 ..
07/28 NOVARTIS : Researchers Submit Patent Application, "3'-[(2z)-[1-(3,4-Dimethylphen..
07/27DJAmgen Profit Rises 13%, 2016 Outlook Raised
07/27DJGLAXOSMITHKLINE : Helped and Hurt by Sterling's Post-Brexit Fall
07/27 NOVARTIS : Guidepost Solutions Appoints Sokolow Former Novartis Services General..
07/26 ELI LILLY : New Animal Drugs; Change of Sponsor
07/26DJEli Lilly Revenue Rise Helped by New Products
07/25DJSTADA ARZNEIMITTEL : Feels More Heat From Active Ownership
07/22 NOVARTIS : IGI Securities Limited - Investor Kit
07/21 NOVARTIS : Patent Issued for Compounds Containing S-N-Valeryl-N-{-Methyl)-Valine..
07/21 NOVARTIS : IGI Securities Limited - Investor Kit
07/20DJBusiness Watch -- WSJ
07/19 NOVARTIS : Generic drug competition hits Novartis sales
07/19 NOVARTIS : beats 2Q profit forecasts
Prev.1   2  3  4  5  6  7  8  9  10Next
Advertisement
Financials ($)
Sales 2016 48 896 M
EBIT 2016 11 366 M
Net income 2016 7 821 M
Debt 2016 14 751 M
Yield 2016 3,61%
P/E ratio 2016 22,74
P/E ratio 2017 20,77
EV / Sales 2016 4,55x
EV / Sales 2017 4,41x
Capitalization 207 776 M
More Financials
Chart NOVARTIS AG
Duration : Period :
Novartis AG Technical Analysis Chart | NOVN | CH0012005267 | 4-Traders
Full-screen chart
Technical analysis trends NOVARTIS AG
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 89,9 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Joseph Jimenez Chief Executive Officer
Hans Jörg Reinhardt Independent Non-Executive Chairman
Harry Kirsch Chief Financial Officer
Vasant Narasimhan Chief Medical Officer & Head-Drug Development
Srikant Madhav Datar Independent Non-Executive Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
NOVARTIS AG-11.00%207 776
JOHNSON & JOHNSON15.00%323 189
ROCHE HOLDING LTD.-12.52%214 851
PFIZER INC.4.93%205 444
MERCK & CO., INC.18.16%172 577
GLAXOSMITHKLINE PLC19.67%103 947
More Results